Research programme: insulin receptor activators - Telik

Drug Profile

Research programme: insulin receptor activators - Telik

Alternative Names: TLK 19781

Latest Information Update: 11 Oct 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Telik
  • Class Small molecules
  • Mechanism of Action Insulin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 19 Aug 2008 Telik's insulin receptor activators programme licensed to ReceptorBio worldwide
  • 19 Aug 2008 Preclinical trials for Type-2 diabetes mellitus in USA (PO)
  • 17 Jan 2005 This programme is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top